THE IADR/AADR publish JDR special issue on head and neck cancer

May 16, 2018

Alexandria, VA, USA - The International and American Associations for Dental Research (IADR/AADR) have published a special issue in the Journal of Dental Research (JDR) on head and neck cancer. Dr. Jacques E. Nör, University of Michigan, Ann Arbor, USA and Dr. J. Silvio Gutkind, University of California, San Diego, USA, served as the guest editors of this special issue.

Head and neck cancer encompasses a large and diverse group of tumors with complex etiology and pathobiology that is typically resistant to therapy, particularly when diagnosed in advanced stages. The most common of these tumors are head and neck squamous cell carcinomas (HNSCC), which are diagnosed in about half million people and result in a quarter million deaths every year worldwide. Unfortunately, the overall 5-year survival of HNSCC patients has remained low at about 50-60% for the last 3-4 decades. The lack of more effective therapies has been attributed to late diagnosis and to the intrinsic resistance of HNSCC cells to existing treatment modalities.

In recent years, the prospect of developing safe and efficient therapies for HNSCC has improved by a deeper understanding of the precise mechanisms underlying the biology of these tumors. This special issue of the Journal of Dental Research brings together leaders in the field who discuss the state-of-the science in head and neck cancer and present new early diagnostic tools and mechanism-based and immune therapies that might benefit patients with this malignancy.

"We are witnessing a revolution in our understanding of HNSCC molecular pathobiology, and in the diagnosis and treatment of this malignancy," said Gutkind and Nör. "The work performed by dedicated investigators is shining new light on HNSCC initiation and progression, and breaking new grounds on the discovery of novel prevention modalities and precision targeted and immune therapies. Collectively, these major research efforts aim at improving the survival and quality of life of patients with head and neck cancer."

This special issue includes articles on topics such as: The changing landscape in head and neck etiology, the elucidation of the head and neck cancer oncogenome, new precision therapies, the immune therapy revolution and improvements with early diagnosis.

This special issue is accompanied by an Editorial "Head and Neck Cancer in the New Era of Precision Medicine." This Editorial is an Editor's Choice article and will be open access.
-end-
To read the JDR special issue on head and neck cancer, please visit http://journals.sagepub.com/toc/jdrb/current or contact Elise Bender ebender@iadr.org to access to the issue.

About the Journal of Dental Research

The IADR/AADR Journal of Dental Research is a multidisciplinary journal dedicated to the dissemination of new knowledge in all sciences relevant to dentistry and the oral cavity and associated structures in health and disease. At 0.02225, the JDR holds the highest Eigenfactor® Score of all dental journals publishing original research. The JDR ranks #1 in Article Influence and #2 in the Two-Year Journal Impact Factor rankings with a rating of 4.755 according to the 2016 Journal Citation Reports® (Clarivate Analytics, 2017).

About the International Association for Dental Research

The International Association for Dental Research (IADR) is a nonprofit organization with over 10,500 individual members worldwide, dedicated to: (1) advancing research and increasing knowledge for the improvement of oral health worldwide, (2) supporting and representing the oral health research community, and (3) facilitating the communication and application of research findings. To learn more, visit http://www.iadr.org. The American Association for Dental Research (AADR) is the largest Division of IADR, with 3,400 members in the United States. To learn more, visit http://www.iadr.org/aadr.

International & American Associations for Dental Research

Related Tumors Articles from Brightsurf:

A viable vaccine for tough tumors
While immunotherapies work well for some cancers, others are immune-resistant and condemn patients to the severe side effects of long-term chemo treatment.

Women could conceive after ovarian tumors
Women receiving fertility-sparing surgery for treatment of borderline ovarian tumours were able to have children, a study from Karolinska Institutet in Sweden published in Fertility & Sterility shows.

Attacking tumors from the inside
A new technology that allows researchers to peer inside malignant tumors shows that two experimental drugs can normalize aberrant blood vessels, oxygenation, and other aspects of the tumor microenvironment in non-small cell lung cancer (NSCLC), helping to suppress the tumor's growth and spread, UT Southwestern researchers report.

Directing nanoparticles straight to tumors
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue.

A solid vaccine for liquid tumors
Acute myeloid leukemia (AML) is a deadly blood cancer that kills most of its victims within five years.

Evolutionarily novel genes work in tumors
A team of scientists from Peter the Great St. Petersburg Polytechnic University studied the evolutionary ages of human genes and identified a new class of them expressed in tumors -- tumor specifically expressed, evolutionarily novel (TSEEN) genes.

Identification of all types of germ cells tumors
Germ cell tumors were considered very heterogeneous and diverse, until recently.

Laser light detects tumors
A team of researchers from Jena presents a groundbreaking new method for the rapid, gentle and reliable detection of tumors with laser light.

Better prognosticating for dogs with mammary tumors
For dogs with mammary tumors, deciding a course of treatment can depend on a variety of factors, some of which may seem to contradict one another.

The evolution of brain tumors
Scientists from the German Cancer Research Center found in a recent study that only three different genetic alterations drive the early development of malignant glioblastomas.

Read More: Tumors News and Tumors Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.